• Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection

  • Feb 28 2025
  • Durée: 29 min
  • Podcast

Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection

  • Résumé

  • How does lymph node assessment play a pivotal role in personalized, multidisciplinary care?

    Credit available for this activity expires: 2/24/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002279?ecd=bdc_podcast_libsyn_mscpedu

    Voir plus Voir moins

Ce que les auditeurs disent de Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.